Veterans’ RightsAn independent resource for veterans
← All decisions
Remanded (sent back)

The Veteran's lung cancer, status post left lobectomy, is being remanded for further evaluation due to noncompliance with the July 2019 remand directives. The claim will be readjudicated after a VA examination.

The deciding factor: The Board found that there was noncompliance with the July 2019 remand directives and thus requires another VA examination to determine the current severity of the Veteran's lung cancer.

Claimed conditions
lung cancer, status post left lobectomy
How they argued it
Presumptive (no nexus needed)
Exposure basis
None
Rating assigned
None in this decision
Decision date
December 17, 2022
Citation
22069584

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 22069584.

What this means for you

A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.